Therefore, further studies are necessary to evaluate if hypoglycosylation of αDG affects laminin binding or other functions of αDG in different types of muscular dystrophies other than dystroglycanopathy. The gene discussed is LAMB2; the disease is neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.